Literature DB >> 8572655

Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy.

J H Cross1, A Connelly, G D Jackson, C L Johnson, B G Neville, D G Gadian.   

Abstract

We performed proton magnetic resonance spectroscopy of the mesial temporal regions in 20 children with intractable temporal lobe epilepsy and compared results with those from 13 normal subjects. Abnormalities of the ratio of N-acetylaspartate to choline plus creatine (NAA/[Cho+Cr]) were seen in 15 patients (75%). The ratio NAA/(Cho+Cr) was correctly lateralizing in 55% and incorrectly lateralizing in none. Bilateral abnormalities were seen in 45%. Overall there was a unilateral decrease in N-acetylaspartate on the side ipsilateral to the seizure focus (mean 19% decrease vs normals, with 5% decrease on the contralateral side), suggesting neuronal loss or dysfunction. There was also a bilateral increase in creatine and choline (mean 18%), consistent with reactive astrocytosis. We conclude that proton magnetic resonance spectroscopy can contribute to lateralization of the seizure focus, and by detection of bilateral abnormalities, can contribute to the understanding of the underlying pathophysiology in temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572655     DOI: 10.1002/ana.410390116

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  Update on surgery for epilepsy.

Authors:  J H Cross
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Extent of preoperative abnormalities and focus lateralization predict postoperative normalization of contralateral 1H-magnetic resonance spectroscopy metabolite levels in patients with temporal lobe epilepsy.

Authors:  G Lantz; M Seeck; F Lazeyras
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

Review 3.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

4.  Usefulness of single voxel proton MR spectroscopy in the evaluation of hippocampal sclerosis.

Authors:  K H Chang; H D Kim; S W Park; I C Song; I K Yu; M H Han; S K Lee; C K Chung; Y H Park
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

Review 5.  Status epilepticus: pathophysiology, epidemiology, and outcomes.

Authors:  R C Scott; R A Surtees; B G Neville
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

6.  Lateralizing ability of single-voxel proton mr spectroscopy in hippocampal sclerosis: comparison with mr imaging and positron emission tomography.

Authors:  S W Park; K H Chang; H D Kim; I C Song; D S Lee; S K Lee; C K Chung; I K Yu; M H Han; Y H Park
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging.

Authors:  R L Wolf; D C Alsop; I Levy-Reis; P T Meyer; J A Maldjian; J Gonzalez-Atavales; J A French; A Alavi; J A Detre
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

8.  Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy.

Authors:  R C Knowlton; K D Laxer; G Ende; R A Hawkins; S T Wong; G B Matson; H A Rowley; G Fein; M W Weiner
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

9.  Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a (1)H magnetic resonance spectroscopy study.

Authors:  F Zubler; M Seeck; T Landis; F Henry; F Lazeyras
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 10.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.